Mouse model of X-linked Alport syndrome

被引:91
|
作者
Rheault, MN
Kren, SM
Thielen, BK
Mesa, HA
Crosson, JT
Thomas, W
Sado, Y
Kashtan, CE
Segal, Y
机构
[1] Univ Minnesota, Dept Pediat, Div Pediat Nephrol, Minneapolis, MN USA
[2] Univ Minnesota, Dept Med, Div Renal Dis & Hypertens, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
[5] Shigei Med Res Inst, Okayama, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2004年 / 15卷 / 06期
关键词
D O I
10.1097/01.ASN.0000130562.90255.8F
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
X-linked Alport syndrome (XLAS) is a progressive disorder of basement membranes caused by mutations in the COL4A5 gene, encoding the alpha5 chain of type IV collagen. A mouse model of this disorder- was generated by targeting a human nonsense mutation, G5X, to the mouse Col4a5 gene. As predicted for a nonsense mutation, hemizygous mutant male mice are null and heterozygous carrier female mice are mosaic for alpha5(IV) chain expression. Mutant male mice and carrier female mice are viable through reproductive age and fertile. Mutant male mice died spontaneously at 6 to 34 wk of age, and carrier female mice died at 8 to 45 wk of age, manifesting proteinuria, azotemia, and progressive and manifold histologic abnormalities of the kidney glomerulus and tubulointerstitium. Ultrastructural abnormalities of the glomerular basement membrane, including lamellation and splitting, were characteristic of human XLAS. The mouse model described here recapitulates essential clinical and pathologic findings of human XLAS. With alpha5(IV) expression reflecting X-inactivation patterns, it will be especially useful in studying determinants of disease variability in the carrier state.
引用
收藏
页码:1466 / 1474
页数:9
相关论文
共 50 条
  • [31] A family with X-linked Alport syndrome confirmed by skin biopsy
    Komatsuda, A
    Ohtani, H
    Wakui, H
    Tokuda, N
    Nakamoto, Y
    Sado, Y
    Naitoh, I
    Imai, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) : 1145 - 1147
  • [32] X-LINKED ALPORT SYNDROME IN FEMALES: EXPIRIENCE OF ONE CENTER
    Aksenova, Marina
    Shagam, Lev
    Konkova, Nataliya
    Dlin, Vladimir
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1913 - 1913
  • [33] Corneal endothelial cell abnormalities in X-linked Alport syndrome
    Nicklason, Eleanor
    Mack, Heather
    Beltz, Jacqueline
    Jacob, Julie
    Farahani, Mina
    Colville, Deb
    Savige, Judy
    OPHTHALMIC GENETICS, 2020, 41 (01) : 13 - 19
  • [34] A Novel Deep Learning Approach for Analyzing Glomerular Basement Membrane Lesions in a Mouse Model of X-Linked Alport Syndrome
    Kawanishi, Kunio
    Baba, Masaki
    Kobayashi, Ryosuke
    Hori, Ryotaro
    Hashikami, Kentaro
    Danbayashi, Kenta
    Iwachido, Takako
    Kato, Mitsuyasu
    AMERICAN JOURNAL OF PATHOLOGY, 2025, 195 (01): : 143 - 154
  • [35] A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene
    Wu, Wei-qing
    Zhang, Jia-xun
    Cui, Ying-xia
    Zhang, Ming-chao
    Chen, Xiao-hang
    Duan, Shan
    Zeng, Cai-hong
    Li, Pei-ning
    Li, Xiao-jun
    FRONTIERS IN MEDICINE, 2023, 10
  • [36] Analyzing three pedigrees in X-linked Alport syndrome with the presentation of nephrotic syndrome
    Zhang, Jian-Hui
    Liu, Jie
    Ruan, Dan-Dan
    Chen, Qian
    Yang, Jie
    Wu, Min
    Yu, Hong-Ping
    Liao, Li-Sheng
    Zheng, Xiao-Ling
    Luo, Jie-Wei
    Zhang, Li
    FRONTIERS IN GENETICS, 2024, 15
  • [37] PREDICTORS OF KIDNEY DISEASE PROGRESSION IN MALES WITH X-LINKED ALPORT SYNDROME
    Aksenova, Marina
    Zaikova, Natalia
    Piruzeeva, Oxana
    Lepaeva, Tatjana
    Obuhova, Varvara
    Nikishina, Tatjana
    Konkova, Natalia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I476 - I476
  • [38] COMPARISON OF CLINICAL COURSE OF X-LINKED ALPORT SYNDROME IN GIRLS AND BOYS
    Bashirova, Zilya
    Papij, Svetlana
    Prikhodina, Larisa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 308 - 308
  • [39] MOLECULAR AND IMMUNOLOGICAL STUDIES IN X-LINKED AND AUTOSOMAL RECESSIVE ALPORT SYNDROME
    LEMMINK, HH
    VANDENHEUVEL, L
    SCHRODER, CAH
    NILLESEN, W
    VANOOST, BA
    BRUNNER, HG
    MONNENS, LAH
    SMEETS, HJM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 629 - 629
  • [40] Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine
    Sigmundsson, Thorir Svavar
    Palsson, Runolfur
    Hardarson, Sverrir
    Edvardsson, Vidar
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2006, 40 (06): : 522 - 525